Will Kenton September 10, 2025 at 7:45 AM A pensive man considering his options. Rob is a 28-year-old office worker with $25,000 in student
Uncategorized
Andy Cohen Shares Surprising Admission About Weight Loss Medication
Andy Cohen got real about his health journey when he admitted to “micro-dosing” on a GLP-1 weight loss medication. “I was really unhappy with
Here's Why XRP Could Be About to Soar
It was a quiet August for XRP, but positive news could be just weeks away. Once the hottest cryptocurrency in the world, XRP (XRP
Regulators Consider 24/7 Trading. Here's What Investors Need to Know
Emma Newbery, The Motley Fool September 9, 2025 at 7:13 AM Key Points The SEC and CFTC are shaking the status quo. Whether it’s
Oprah Winfrey, 71, looks unrecognisable as talk show host shows off dramatic 22kg Ozempic weight loss transformation
Oprah Winfrey looks unrecognisable as she showed off her dramatic weight loss transformation in a stunning new Instagram post. The 71-year-old talk show host
Dwayne 'The Rock' Johnson Declares He's 'Not Done' Losing Weight After Shedding 30 Pounds of Muscle…As Actor Ignores Fans' Concerns About His Health
Daniel Gura September 9, 2025 at 5:15 PM Dwayne Johnson has dropped 30 pounds of muscle, with plans to drop more.mega Dwayne ‘The Rock’
SEC Crypto Task Force Announces New Key Crypto Roundtable
The United States Securities and Exchange Commission’s (SEC) Crypto Task Force will host a key hearing on financial privacy and surveillance on October 17,
Andy Cohen Opens Up About Weight Loss Journey and ‘Micro-Dosing a GLP-1’ to Curb Cravings
Andy Cohen revealed the secrets behind his slimmer figure after losing “a good chunk of weight” this summer. The king of Bravo tea, 57,
Andy Cohen reveals he’s ‘microdosing’ GLP-1 weight loss drugs
Andy Cohen is the latest celebrity to reveal he’s using medication for weight loss. The reality TV kingpin has opened up on his experience
GLP-1 Weight-Loss Injections May Pose 'Hidden Risks' to Young Women
GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research